This is only a tiny blip. A large portion of the research on psychiatric drugs is compromised by complex and multifaceted pharmaceutical industry influence. The entire database is grossly unreliable as a result and meta-analyses cannot be taken at face value. I can provide many good references on this if anyone is interested.

Paul Okami


----- Original Message ----- From: "Joan Warmbold" <[EMAIL PROTECTED]> To: "Teaching in the Psychological Sciences (TIPS)" <tips@acsun.frostburg.edu>
Sent: Saturday, December 06, 2008 5:05 PM
Subject: [tips] Conflicts of Interest for Psychiatrists recommending medications


http://www.nytimes.com/2008/11/22/health/22radio.html?ref=business

This article is alarming in the extent of serious ethical judgments it
reveals various psychiatrists have made by recommending medications
produced by the companies that are paying them big bucks as to act as
"consultants."   The article centers on the efforts by Senator Grassley to
check for any conflicts of interests within the psychiatric community and
what he has discovered, to date, is shocking.  For example, on a regular
show on NPR Dr. Goodwin highly touted to parents the use of
mood-stabilizers for their children who have been diagnosed as bi-polar
while simultaneously being paid by a pharmaceutical company that produced
these medications.  Though he has personally received $1.3 million for his
"consulting" work with pharmaceutical companies, he never reported such to
NPR.  In another example, Dr. Biederman from Harvard has been a powerful
advocate for the use of powerful antipsychotic drugs for children while
also earning a total of $1.7 million from drugmakers.  Many of you have
already heard about Dr. Nermeroff from Emory who earned $1.2 million from
2000 to 2007 while acting as a strong advocate of the use of medications.
Have any of you heard about any official response or appropriate actions
taken by any of the psychiatric associations?  I haven't been aware of
such and yet these type of stories do great harm to the publics trust of
the clinical field generally.

Joan
Joan Warmbold
[EMAIL PROTECTED]


---
To make changes to your subscription contact:

Bill Southerly ([EMAIL PROTECTED])

__________ NOD32 3632 (20081121) Information __________

This message was checked by NOD32 antivirus system.
http://www.eset.com




---
To make changes to your subscription contact:

Bill Southerly ([EMAIL PROTECTED])

Reply via email to